Covalent Modification of Proteins by Osthole Reactive Metabolites using Proteomic Approaches

Title:Covalent Modification of Proteins by Osthole Reactive Metabolites using Proteomic Approaches

Volume: 24 Issue: 8

Author(s): Yue Zhuo*, Huiling Chen, Chenchen Liu, Yida Zhang, Jiansong Fang, Meng Li, Zhendong Wang, Qiyao Jiang, Liangwen Yu, Huafeng Pan*Qi Wang*

Affiliation:

• Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China

• Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China

• Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China

Abstract:

Background: Osthole (OST) is a bioactive natural coumarin derived from the plant Cnidium monnieri (L.) Cusson fruit (She Chuang Zi), which has various pharmacological and biological activities. OST contains an α,β- unsaturated lactone, which is an electrophilic group that tends to be metabolized into reactive metabolites (RMs). Then, RMs are able to covalently modify nucleophilic amino acid (AA) residues of target proteins. However, few researchers considered the contribution of the covalent modification induced by OST or its metabolites.

Objective: This study aims to investigate the metabolic profile and the metabolites-protein modification of OST.

Methods: The metabolites of OST were qualitatively identified using UHPLC-Q-TOF-MS. The RMs modification patterns and potentially modified AA residues were confirmed by UHPLC-Q-TOF-MS using rat liver microsomes (RLMs) and model AAs. Finally, the modified peptides derived from high-abundance microsomal peptides were separated via nano-LC-Orbitrap-MS, and then RM-modified proteins were identified using a proteome discoverer.

Results: In the presence of RLMs, OST could rapidly be metabolized within 1 h and hardly identified at 4 h. We detected 10 OST metabolites, 13 OST metabolites-NAC (N-acetyl cysteine) adducts, 3 NAL (N-acetyl lysine) adducts, and 11 GSH (glutathione) adducts. Furthermore, 16 RM-modified protein targets were identified, many of which are included in the essential biological processes of OST’s anti-Alzheimer’s disease (AD) and anti-tumor.

Conclusion: This study provides a novel perspective on the molecular mechanism of OST's pharmacological activities, as well as identifies potential targets for further development and application of OST and other Natural products (NPs).

Cite this article as:

Zhuo Yue*, Chen Huiling, Liu Chenchen, Zhang Yida, Fang Jiansong, Li Meng, Wang Zhendong, Jiang Qiyao, Yu Liangwen, Pan Huafeng*, Wang Qi*, Covalent Modification of Proteins by Osthole Reactive Metabolites using Proteomic Approaches, Current Drug Metabolism 2023; 24 (8) . https://dx.doi.org/10.2174/1389200224666230727123006